SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-15-004206
Filing Date
2015-04-30
Accepted
2015-04-30 15:15:43
Documents
6
Period of Report
2015-06-19
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2224515zdef14a.htm DEF 14A 298374
2 G101062BGI001.JPG g101062bgi001.jpg GRAPHIC 76428
3 G101062BGI002.JPG g101062bgi002.jpg GRAPHIC 70118
4 G101062BGI003.JPG g101062bgi003.jpg GRAPHIC 62203
5 G646810.JPG g646810.jpg GRAPHIC 9910
6 G78428.JPG g78428.jpg GRAPHIC 9149
  Complete submission text file 0001047469-15-004206.txt   614026
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36571 | Film No.: 15817800
SIC: 3841 Surgical & Medical Instruments & Apparatus